introduction
Psychosocial intervention in cancer patients is effective [1] [2] [3] [4] , but many distressed cancer patients are not referred 5, 6 . Other forms of care delivery, such as brief therapies, selfhelp, and collaborative care, may overcome barriers to referral 2, 3, 5, 7, 8 . In stepped care (SC), more intensive interventions are reserved for patients who do not benefit from low-intensity interventions [9] [10] [11] . We developed an SC program targeting cancer patients with psychological distress 12 .
The aim of this study was to assess the efficacy of SC to improve psychological distress compared with care as usual (CAU). Secondary aims were to investigate a possible positively moderating effect of the presence of a depressive or anxiety disorder (versus an increased risk for a disorder), and a possible decay of effect of SC in the longterm. Also, possible positive effects of SC on health-related quality of life and satisfaction with care were explored.
patientS and MethodS

STUDy DESIGN AND POPULATION
This study was a monocenter, parallel-group randomized, controlled trial (RCT), and approved by the Medical Ethics Committee of VU University Medical Center and registered in the Netherlands Trial Register (NTR1868) 12 .
Eligible participants were treated with curative intent at least 1 month earlier for head and neck cancer (HNC) or lung cancer (LC) and had psychological distress (Hospital Anxiety and Depression Scale (HADS; HADS-D > 7, HADS-A > 7, or HADS-total > 14)) 13 . Exclusion criteria were (i) cognitive dysfunction, (ii) lack of motivation to undergo psychological therapy, (iii) currently under treatment for a depressive or anxiety disorder, (iv) treatment for a psychiatric disorder < 2 months ago, (v) high suicide risk, (vi) psychotic and/or manic signs (those patients were referred to the psychiatric service), or (vii) insufficient knowledge of the Dutch language. All HNC and LC patients who visited the outpatient clinic for followup consultation between 2009 and 2013 were screened for distress using the HADS via a touchscreen data collection system (OncoQuest) or telephone. All patients with distress received written information and an informed consent form. Patients who returned their signed informed consent had a diagnostic telephone interview (Composite International Diagnostic Interview (CIDI)) 14 . After completion of the interview, patients were randomized into the intervention or control group.
INTERVENTION
A description of the SC program can be found elsewhere 12 . In short, it includes (i) watchful waiting, (ii) guided self-help via the Internet or a booklet, (iii) face-to-face problem-solving therapy, and (iv) specialized psychological interventions and/or psychotropic medication.
Stepping up to the next treatment was mandated when a patient's HADS-A or HADS-D score remained above 7. All care providers were thoroughly trained using protocol in order to limit differences between care professionals. Therefore, major differences in effect between care providers were not expected. In the control group patients received CAU.
OUTCOMES
Outcome measures were collected at baseline (t0), after the intervention period (time depended upon duration of the SC program) or control period (4 months) (t1), and 3 (t2), 6 (t3), 9 (t4), and 12 months after t1 (t5).
The primary outcome measure was the HADS 13 . The HADS is a 14-item selfassessment scale for measuring distress (total HADS score) with two subscales, anxiety (HADS-A) and depression (HADS-D). The total HADS score ranges from 0 to 42, the subscales from 0 to 21.
Secondary outcomes were health-related quality of life (HRQOL) (EORTC QLQ-C30 (version 3.0), QLQ-H&N35, QLQ-LC13), and patient satisfaction with care (EORTC IN-PATSAT32) [15] [16] [17] [18] . Following EORTC guidelines, scores were linearly transformed to 0-100 scores. For the global quality of life scale, functioning scales, and the IN-PATSAT scales, higher scores correspond to better levels of functioning or satisfaction with care, while for symptom scales, higher scores represent higher levels of symptoms/problems. The presence of a depressive or anxiety disorder was assessed according to the CIDI 14 .
SAMPLE SIzE
To demonstrate an improvement of five points (based on average scores in earlier studies 19 ) on the HADS-total scale after 1 year (power 80%, significance level 5%, standard deviation (SD) 7), 66 patients were needed per group (132 patients in total). A study by Puhan et al. 20 , reported that an improvement of about 1.5 on the HADS may already be clinically meaningful for patients.
RANDOMIzATION AND BLINDING
This study was an RCT, with equal randomization [1:1] , and stratification for tumor site (LC versus HNC) and stage (I-II versus III-IV) in blocks of two. Randomization was conducted centrally by an independent statistician. Patients and physicians were aware of treatment allocation, whereas statisticians were blinded. Blinding of patients was not possible since they had been given information about SC before inclusion and consequently recognized the applied intervention.
STATISTICAL ANALySES
Independent samples t-tests and χ 2 tests were used to gauge whether randomization resulted in a balanced distribution of patient characteristics across the experimental conditions. Intention-to-treat analyses were carried out. To test differences between conditions regarding the course of distress, HRQOL, and satisfaction with care from baseline to follow-up, linear mixed models were used with fixed effects for group, measurement, and their two-way interaction, and a random intercept for subjects. To For all statistical analyses, a P value of < .05 was considered statistically significant.
Analyses were carried out with SPSS 20.0 (IBM Corp., Armonk, NY USA).
reSultS
STUDy POPULATION
Patients were screened for distress via the HADS in OncoQuest (2885 times in 920 individual patients) or by telephone (378 patients) ( Figure 1 ). In total, 265 patients met the inclusion and exclusion criteria. Of these patients, 109 patients did not want to participate (n = 102) or could not be contacted (n = 7). In total, 75 were randomized to the intervention and 81 to the control group. The mean time between t0 and t1 of the intervention and control group was comparable (15.0 weeks (SD = 19.5) and 16.3 weeks (SD = 3.6)). At 12 months follow-up (t5), 54 patients in the intervention group and 52 patients in the control group completed the outcome assessment. During the study, 4 patients (5.3%) in the intervention group versus 15 patients (18.5%) in the control group died (P = .012).
The majority was treated for HNC (94%) ( Table 1 ). At baseline, there were no significant differences between the intervention and control group regarding sociodemo graphic and clinical characteristics. A statistically significant difference was found regarding alcohol dependency: patients in the intervention group were more often alcohol dependent (13.3%) than control patients (3.7%). When comparing the outcome measures at baseline ( Table 2, and Table 3 Table 2 . Overview of the course of the HADS scores in the total group, and the course of the HADS scores with respect to presence of a psychiatric disorder (anxiety or depression) 41.4 m = mean; SD = standard deviation; * = .. functioning; ** = problems with .. ; general sf. = general satisfaction; other pers. = other personnel. Significant differences (P < .05) are underlined and clinically relevant differences (>10 points difference) are presented in bold font.
EFFICACy OF THE SC PROGRAM
The course of distress over time (Table 2) was significantly better for the intervention compared with the control group regarding HADS-total (assessment * group: P = .005), HADS-A (assessment * group: P = .046), and HADS-D (assessment * group: P = .007).
After correcting for time between t0 and t1, the course of distress over time was still significantly better regarding HADS-total (assessment * group: P = .006), HADS-A (assessment * group: P = .0496), and HADS-D (assessment * group: P = .008). When adjusting for baseline HADS, the course of distress over time was still significantly better (HADS-total (assessment * group: P = .002 and HADS-D (assessment * group: P < .001), except for HADS-A (assessment * group: P = .061). At t1, the intervention group scored significantly better regarding HADS-total (P = .001; ES = 0.56), HADS-A (P = .024; ES = 0.38), and HADS-D (P < .001; ES = 0.64). At t2, t3, and t5 (3, 6 , and 12 months followup), there were no significant differences between the two groups. At t4 (9 months follow-up), the intervention group scored significantly better on HADS-total (P = .033; ES = 0.42) and HADS-A (P = .04; ES = 0.40).
The SC program had more influence on the course of distress among patients with a depressive or anxiety disorder compared with patients without a psychiatric disorder, regarding HADS-total (P = .001), HADS-A (P = .003), and HADS-D (P = .041) ( Table 2 ).
The recovery rate of distress (HADS-A ≤ 7 and HADS-D ≤ 7) at t1 was 54.8% in the intervention group versus 29.2% in the control group (χ 2 = 9.769; P = .002), and at t5 this was 45.5% in the intervention versus 36.5% in the control group (χ 2 = 0.878; P = .349). In total, 28% recovered after watchful waiting, 34% after guided self-help, 9% after problem-solving therapy, and 17% after psychotherapy and/or psychotropic medication).
For patients in the control group, CAU mostly consisted of no additional care (72.2%), while in some cases psychiatric or psychological treatment (8.3%) and/or psychotropic medication (22.2%) was provided.
Results on HRQOL and satisfaction with care are presented in Table 3 . Results of the QLQ-LC13 are not presented because of the small number of LC patients. The course of the QLQ-C30 emotional functioning scale was significantly different for the intervention compared with the control group (assessment * group: P = .033). Post-treatment (t1), patients in the intervention group scored clinically and statistically significantly better on role, emotional, cognitive, and social functioning (QLQ-C30), and social contacts and sexual functioning (QLQ-H&N35). At 3 months follow-up (t2), this positive effect remained regarding social functioning and social contacts. Also, at t2, patients in the intervention group reported less trouble with social eating. At 9 months follow-up (t4), patients in the intervention group had statistically and clinically better scores regarding cognitive functioning and social contacts. At 6 (t3) and 12 (t5) months follow-up, there were no significant differences between the two groups.
diScuSSion
SC is effective to reduce distress and improve HRQOL among HNC and possibly LC patients. The course of distress from baseline to 12 months follow-up was significantly better for the intervention group compared with the control group. ES at separate time points revealed moderate to strong effects of SC on distress and several HRQOL aspects post-treatment and at short-term follow-up, but no longer at 12 months follow-up (decay effect). Also, the recovery rate was significantly higher post-treatment (55% in the intervention group versus 29% in the control group) but not at 12 months follow-up (46% versus 37%, respectively). Thus, SC seems to speed up recovery of distress and improvement of HRQOL.
A meta-analysis on RCTs (n = 14) on SC for depression in a mixed population also
showed that SC has a moderate effect on depression (pooled ES of 0.34 (95% confidence interval 0.20-0.48)) 23 . The SC interventions varied greatly in number of treatment steps, treatments offered, professionals involved, and criteria to step up, which makes it difficult to compare study outcomes. A study among breast cancer patients 7 reported on an SC program with two steps (stress management education (all patients), followed by a stress management intervention (patients with distress)), which is clearly different from our approach with four steps. It was striking that in our study almost 30% of distressed cancer patients recovered after 2 weeks of watchful waiting. This percentage is much higher compared with the 5% after 4 weeks of watchful waiting among primary care patients with a depressive or anxiety disorder 24 . The percentage of recovered cancer patients after step 2 of the SC program (guided self-help) was also much higher: 34% versus 9% in the previous study. An explanation might be that cancer patients were screened for distress and entered the SC program at the time of their medical follow-up consultation, which is often very stressful. After reassurance that malignancy has not recurred, distress may resolve spontaneously.
The SC program was especially beneficial for cancer patients suffering from a depressive or anxiety disorder. Patients with psychological distress (but not a psychiatric disorder) did benefit from CAU as much as from SC.
The research findings should be held against some limitations of this study. We included 156 cancer patients, but only 106 had complete data at 12 months follow-up.
Significantly fewer patients died in the intervention compared with the control group (5.3% versus 18.5%). Depression and HRQOL are related to survival and a debate is ongoing on the effect of psychosocial interventions on survival 25, 26 . However, it seems unlikely that higher survival was an effect of SC, since the effect of SC on distress was no longer present at 12 months follow-up. Another limitation is that some small differences between the two groups were observed at baseline. Some differences where in favor of the intervention group (i.e. better scores for depression, social functioning, social contact, and sexuality), while others were at the expense of the intervention group (i.e.
worse scores for patient satisfaction and alcohol dependency). These differences were considered to be coincidental: additional analyses adjusting for baseline depression did not influence the findings. Furthermore, only a small number of LC patients participated.
The prevalence of distress among LC patients was much lower than anticipated 27 . Further research is needed to obtain more insight into these unexpected findings.
The influence of the level of psychological distress on the efficacy of SC and the fact that almost one third of cancer patients who screen positive for distress recover after a period of watchful waiting sheds a new light on the ongoing debate on the benefit of screening for distress in clinical practice 5, 28, 29 . In our opinion, it is important that decisions about treatment provision are monitored systematically, and changes are made if current treatments do not achieve a significant health gain. Further research is needed to predict whether a patient needs the entire SC model or can skip a step, based on which SC can be further improved towards a personalized SC approach.
